中国医学创新  2025, Vol. 22 Issue (27): 135-139    DOI: 10.3969/j.issn.1674-4985.2025.27.032
Experiential exchange Current Issue | Archive | Adv Search |
Clinical Study of Combined Treatment with Tislelizumab and GC Chemotherapy Regimen for Bladder Cancer
YANG Yongsheng, HUANG Bo, QIU Changying
First-author's address: Department of Urology, Yingtan City People's Hospital, Yingtan 335000, China
© 2016 中国医学创新 editorial
Address: Beijing south cellular road number five      Postcodes: 100055